GlassScriptPhysician profile
Michael R Langlois
NPI 1780867754
$8,447.71
in general payments reported to CMS, 2019-2025
24 companies · $3,659 in 2025
The $3,659 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $717 · 2021: $383 · 2022: $234 · 2023: $1,219 · 2024: $1,106 · 2025: $3,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,023 · Food and Beverage: $2,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,022.77 |
| Food and Beverage | $2,962.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,883.47 | 2022-2025 | |
| Stryker Corporation | $1,578.52 | 2019-2025 | Anchorage, Axsos, Allograft |
| Paratek Pharmaceuticals, INC. | $639.63 | 2023-2025 | Nuzyra, Xhance |
| Wright Medical Technology, INC. | $528.69 | 2019 | |
| Mission Medical Distribution, LLC | $515.09 | 2024-2025 | |
| Smith+Nephew, INC. | $496.51 | 2019-2025 | Collagenase Santyl, Regranex |
| Arthrex, INC. | $484.90 | 2025 | |
| Sanara Medtech INC. | $192.35 | 2024 | Celleraterx |
| Misonix INC | $190.41 | 2019-2020 | |
| Organogenesis INC. | $172.93 | 2019-2023 | Affinity |
| Aroa Biosurgery Incorporated | $139.36 | 2025 | |
| Bone Support INC. | $128.33 | 2025 | Cerament G, Ceramentbone Void Filler |
| Kerecis Limited | $112.26 | 2019-2021 | |
| Horizon Therapeutics Plc | $84.88 | 2019 | |
| Depuy Synthes Sales INC. | $49.86 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $45.07 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acumed LLC | $44.54 | 2021 | |
| Triad Life Sciences INC. | $43.92 | 2022 | |
| Tactile Systems Technology INC | $38.61 | 2020-2022 | |
| Lifenet Health | $19.89 | 2023 | |
| Abbott Laboratories | $16.19 | 2024 | Proclaim |
| Bioventus LLC | $15.56 | 2019 | |
| Ibsa Pharma INC. | $14.84 | 2024 | Tirosint, Licart |
| Davol INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Langlois listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.